Indrayani Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/08/2026 ,inter alia, to consider and approve Indrayani Biotech Ltd has ....

12.08.2026 Department of Corporate Services, BSE Limited, P.J. Tower, Dalal Street, Mumbai – 400001. Scrip Code: 526445 Dear Sir/ Madam Sub: Intimation of Board Meeting under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Pursuant to Regulation 29 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to intimate that, Meeting of the Board of Directors will be held on Monday, 17 August, 2026, inter alia, to consider and approve the following: 1. Approval of audited financial statements of the company for the Quarter and Financial Year ended March 31, 2026 along with notes thereon and to authorise directors to sign the same. 2. To take on record the Auditors Report on the financials for the Financial Year ended March 31, 2026. 3. Approval of the Audited Financial Results for the Quarter and financial year ended March 31, 2026 to be disseminated to stock exchange and approval of the text of advertisement for publication in newspapers. 4. Any other business with permission of the chair. You are requested to take the above on record and disseminate the information on your website. Thanking you. For and Behalf of Indrayani Biotech Limited Swaminathan Govindarajan Whole-time Director DIN: 02481041 Block 1, 33, SIDCO Electronic Complex, Thiru Vi Ka Industrial Estate, Guindy, Chennai 600032 Ph: +91-44-24463751 / +91-44-22502146 | www.indrayani.com | info@indrayani.com | CIN: L40100TN1992PLC129301